Page last updated: 2024-09-03

aj 76 and domperidone

aj 76 has been researched along with domperidone in 3 studies

Compound Research Comparison

Studies
(aj 76)
Trials
(aj 76)
Recent Studies (post-2010)
(aj 76)
Studies
(domperidone)
Trials
(domperidone)
Recent Studies (post-2010) (domperidone)
37021,977275468

Protein Interaction Comparison

ProteinTaxonomyaj 76 (IC50)domperidone (IC50)
Solute carrier family 22 member 2Homo sapiens (human)7.9
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)1.332
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)2.614
Alpha-2A adrenergic receptorHomo sapiens (human)2.74
D(2) dopamine receptorHomo sapiens (human)0.0026
Alpha-2B adrenergic receptorHomo sapiens (human)2.125
Alpha-2C adrenergic receptorHomo sapiens (human)1.011
Sodium-dependent noradrenaline transporter Homo sapiens (human)2.614
Alpha-1D adrenergic receptorHomo sapiens (human)1.065
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.037
5-hydroxytryptamine receptor 2CHomo sapiens (human)1.332
Sodium-dependent serotonin transporterHomo sapiens (human)3.055
Histamine H1 receptorHomo sapiens (human)1.344
Mu-type opioid receptorHomo sapiens (human)4.218
D(3) dopamine receptorHomo sapiens (human)0.018
Kappa-type opioid receptorHomo sapiens (human)6.994
5-hydroxytryptamine receptor 2BHomo sapiens (human)2.6
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0052
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.1447
Multidrug and toxin extrusion protein 1Homo sapiens (human)2.3

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrieux, M; Besançon, R; Giros, B; Martres, MP; Pilon, C; Schwartz, JC; Sokoloff, P1
Bouthenet, ML; Giros, B; Martres, MP; Schwartz, JC; Sokoloff, P1
Fang, X; Hu, Z; Levant, B; Min, J; Varady, J; Wang, S; Wu, X1

Other Studies

3 other study(ies) available for aj 76 and domperidone

ArticleYear
Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor.
    European journal of pharmacology, 1992, Apr-10, Volume: 225, Issue:4

    Topics: Animals; Chlorides; CHO Cells; Cricetinae; Dopamine; Dopamine Agents; Dopamine Antagonists; Guanylyl Imidodiphosphate; Humans; Lithium; Lithium Chloride; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Sodium Chloride; Sulpiride; Transfection

1992
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.
    Nature, 1990, Sep-13, Volume: 347, Issue:6289

    Topics: Amino Acid Sequence; Animals; Antipsychotic Agents; Base Sequence; Brain Chemistry; Cell Line; Cloning, Molecular; Cricetinae; DNA; DNA Restriction Enzymes; Dopamine; Guanylyl Imidodiphosphate; Molecular Sequence Data; Nucleic Acid Hybridization; Polymerase Chain Reaction; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Sequence Homology, Nucleic Acid; Tissue Distribution

1990
Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.
    Journal of medicinal chemistry, 2003, Oct-09, Volume: 46, Issue:21

    Topics: Algorithms; Binding Sites; Computational Biology; Crystallography, X-Ray; Databases, Protein; Humans; Kinetics; Ligands; Lipid Bilayers; Models, Molecular; Molecular Conformation; Mutation; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Solvents; Structure-Activity Relationship; Tetrahydronaphthalenes; Water

2003